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Abstract
Background: Health-care professionals have a responsibility to be attentive to patients’ adherence behavior but it
could be difficult to identify poor adherence in the context of clinical practice. Assessment of personality could be
used to identify individuals who are in need for support with their adherence behavior. To our knowledge, existing
adherence questionnaires are not based on individuals reflecting asthmatics in the general population and there is
limited research describing adherence with asthma medication in relation to personal goals with the treatment. The
aim was to develop and validate an adherence questionnaire in adult individuals with asthma from the general
population and to assess adherence in relation to personality traits and goals with the asthma medication using the
developed questionnaire.
Methods: The study was conducted in three phases: 1. A preliminary postal 46-item questionnaire was refined after
psychometric testing (n = 157). 2. The questionnaire was validated (n = 104). 3. The developed adherence
questionnaire was analyzed in relation to personality traits and achieved goals with the asthma medication. Adult
respondents with physician diagnosed asthma using asthma medications were selected from the population-based
West Sweden Asthma Study. The respondents completed the Neuroticism, Extraversion and Openness to
Experience Five-Factor Inventory and the Medication Adherence Report Scale and stated their goals with the
asthma medication. Data were analyzed using t-tests, correlations, multiple regression and principal component
analysis.
Results: A final questionnaire was developed consisting of ten items organized in three subscales - “medication
routines”, “self-adjusting the medication” and “concerns about side-effects”. Two of the subscales - “medication
routines” and “self-adjusting the medication” – were associated with the Medication Adherence Report Scale. The
subscale “medication routines” was associated with the personality traits – Conscientiousness and Neuroticism and
unachieved goals with the asthma medication.
Conclusions: The developed questionnaire appears to be useful for measuring adherence to asthma medication in
adult individuals with asthma. The study suggests that both individual differences and personal treatment goals
need to be addressed in efforts to promote adherence to asthma medication treatment.
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Background
Several studies have reported that adherence to asthma
medication treatment among individuals with asthma
could be better [1–4]. At the same time, health-care pro-
fessionals have a responsibility to promote improved
adherence [5], and it has been recommended that adher-
ence to asthma medication be checked during follow-
ups at asthma clinics [6]. However, as regards adherence
estimations in daily clinical practice, it may be difficult
to estimate accurate adherence levels. One common
method of estimating adherence to medication treat-
ment is through self-report, which usually is conducted
using questionnaires or interviews about medication use
[7]. This method of estimating adherence has the advan-
tage of being cost-effective and suitable for use in daily
clinical practice [5]. Though, self-report as a method has
drawbacks in terms of recall bias [8] and social desirabil-
ity bias [5, 7], the latter possibly resulting in overesti-
mation of adherence [5]. Comparing self-report to other
methods used to assess adherence, one study showed
positive associations between self-reported adherence
and adherence measured electronically [9], but another
study demonstrated that canister weight and electronic
monitoring were more reliable than self-reports [10].
Still, a meta-analysis concluded that self-reported adher-
ence gives a good estimation of adherence to medication
treatment [11]. It has also been argued that self-reports
of low adherence can be regarded as reliable [5].
Additionally, self-reports provide valuable information of
patients’ problems with adherence. Canister weight and
electronic monitoring do not provide that kind of infor-
mation and these two adherence measurements may not
be possible or suitable to use in daily clinical practice [7].
It has also been argued that it may be difficult to iden-
tify which patients are likely to deviate from a prescribed
treatment [7]. Previous research has shown that assess-
ment of personality traits could be one method to iden-
tify personal resources and needs of significance for
adherence behavior in relation to asthma medication
treatment [12–14]. The five-factor model describes per-
sonality in terms of five broad and bipolar personality
traits: Neuroticism, Extraversion, Openness, Agreeable-
ness and Conscientiousness [15]. In individuals with
asthma, Neuroticism has been associated with lower
adherence [14], while Conscientiousness has been asso-
ciated with higher adherence to asthma medication
treatment [13, 14].
Asthma control [12, 16] and health-related quality of
life [17, 18] are often used as outcome measures of ad-
herence to asthma medication. For instance, Horne et al.
showed [16] that better symptom control was observed
among individuals with asthma, who reported higher ad-
herence to the medication treatment. Higher adherence
has also been associated with better perceived health-
related quality of life [17]. To the best of our knowledge,
there is limited research describing adherence to asthma
medication in relation to personal goals with the medi-
cation treatment.
In summary, adherence to asthma medication could
be improved [1–4], and health-care professionals have a
responsibility to check adherence [6] but it could be
difficult to identify poor adherence in the context of
clinical practice and to identify which patients are more
likely to deviate from a prescribed treatment [7]. There
is limited research describing adherence in relation to
whether personal goals with the asthma medication have
been achieved or not. To the best of our knowledge,
existing adherence questionnaires are not based on indi-
viduals reflecting asthmatics in the general population.
Methods
Aim
The aim was first to develop and validate an adherence
questionnaire in adult individuals with asthma from the
general population and second to assess adherence in
relation to personality traits and goals with the asthma
medication using the developed questionnaire.
Procedure
The study was conducted in three phases:
1. Development of the adherence questionnaire
2. Validation of the developed adherence questionnaire
3. Assessment of adherence in relation to personality
traits and achieved goals using the developed
questionnaire
Phase 1 – questionnaire development
An “item-pool” consisting of 46 items was generated
based on literature on adherence in combination with
our experience and knowledge from our previous re-
search (Table 1) [12, 14, 19, 20]. A 46-item questionnaire
was constructed that began by explaining the aim of the
questionnaire in an accepting tone. In order to reduce
the risk of social desirability bias, it has been recom-
mended that questions about adherence be posed in a
way that presents missed doses as something normally
occurring [21]. The respondent was asked to take a
position on each statement by choosing among five
response alternatives (“Doesn’t correspond at all”,
“Doesn’t correspond very well”,”Neither corresponds nor
doesn’t correspond”, “Corresponds fairly well”, and
“Corresponds exactly”) on a 5-point Likert-type scale
[22]. The order of the items was constructed so that the
questionnaire did not begin with controversial or
emotive items. There was also a mixture of positive and
negative statements, which is suggested as a method of
minimizing response bias [23].
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The questionnaire was sent by mail to 300 adult indi-
viduals with asthma using asthma medication, selected
at random from the population-based West Sweden
Asthma Study (WSAS). The following is a brief explan-
ation of the WSAS. In 2008, 30,000 randomly selected
individuals were invited to take part in the WSAS, by
postal questionnaires, and 18,087 completed and
returned the questionnaires [24]. Out of the 18,087 indi-
viduals from the general population who completed the
questionnaires, 2006 individuals, including 964 adult
asthmatics, participated in the following clinical phase of
the WSAS . The respondents in the current study have
been selected from the asthma cohort (n = 964), who re-
ported that they had used asthma medication during the
past 12 months. In 2013, they were invited to participate
through one initial mailing of the questionnaire and one
reminder. A completed and returned questionnaire was
regarded as consent to participate in the current study.
Phase 2 – validation of the developed questionnaire
Following psychometric analysis of the questionnaire in
phase 1, a new questionnaire was constructed, similar in
design to that used in phase 1. However, one item was
slightly changed from “I don’t follow the doctor’s pre-
scription exactly but instead I can feel what I need to
Table 1 The item pool. Items marked 1 and 2 were used in
psychometric tests in phase 1 and 2
The condition i.e. asthma
My asthma is mild.
My asthma will never go away.
1 I’ve doubted at times that I really have asthma.
1 My asthma comes and goes.
The treatment
I’m not sure about my inhalation technique.
My asthma inhalator is user friendly.
I don’t know how my asthma medicine works.
My asthma inhalator is difficult to use.
I have different inhalators with asthma medicine and I
don’t really know when I should use one or the other.
The health care
I want to participate in deciding on my asthma medication.
I get enough information about my asthma medicine from
my nurse/doctor.
I wish I got more information about my asthma medicine.
The individual – beliefs about asthma medication
I avoid unnecessary asthma attacks by taking my medicine.
1, 2 I’m worried about how my asthma medicine will affect my
body in the long run.
My asthma medicine prevents me from feeling worse on
account of my asthma.
My asthma medicine is a source of security.
1, 2 I worry about the side-effects of asthma medicine.
1 Thanks to my asthma medicine I hardly know I have asthma.
My asthma could get worse in the future if I don’t take my
asthma medicine now.
1 I’m tired of taking my asthma medicine.
I’m sceptical about my asthma medicine.
1 I don’t like taking medicine unless I feel I need it.
My asthma medicine makes me feel safe and secure.
I think the advantages of taking asthma medicine outweigh
the disadvantages of not taking it.
My asthma medicine makes me feel good and lets me manage
my life well.
The individual – personal characteristics
1 I don’t feel I’m participating as far as my asthma medicine
is concerned.
I prefer cooperating.
I don't like discipline and routines.
I’m a rather insecure person.
I’m usually suspicious of other people’s intentions.
To remember to take asthma medicine you have to have routines
and I’m not really that kind of person. I’m a bit more unstructured.
I often feel worried.
I’m a meticulous person and have routines for my asthma
medicine.
Table 1 The item pool. Items marked 1 and 2 were used in
psychometric tests in phase 1 and 2 (Continued)
The individual – adherence behavior
1, 2 It’s easy to forget asthma medicine.
1, 2 I don’t follow the doctor’s prescription exactly but instead I can
feel what I need to take. 2I don’t follow the doctor’s prescription
of asthma medicine exactly but instead I can feel how much I
need to take.
I really have to struggle to not forget to take my asthma medicine.
Routines are important for helping me remember to take my
asthma medicine.
1, 2 I don’t have any real habits for my asthma medicine but instead
I take them when I remember to.
I can’t manage if I don’t take more asthma medicine than
is prescribed.
1, 2 I don’t use my asthma medicine exactly like my doctor has said.
1, 2 Sometimes I test going without my asthma medicine to see
what it’s like.
1, 2 I don’t really follow the instructions for my asthma medicine but
instead I can feel what my body needs. If I feel I need more, I take
more. If I feel I need less, I take less.
1 I feel I need to take more reliever medicine than is prescribed.
1, 2 I can tell myself how I feel and how much of my asthma medicine
I need to take.
1, 2 I’m like a periodical drinker as far as my asthma medicine is
concerned.
Even though it would be good if I had a routine for my asthma
medicine it’s probably nothing I’m going to do anything about.
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take” to “I don’t follow the doctor’s prescription of
asthma medicine exactly but instead I can feel how
much I need to take.” The change was made in order to
clarify that the item was supposed to assed the self-
adjusting of the doses, which was not clear in the origin
item “what I need to take” and to emphasize that it was
asthma medication that was in focus.
In 2013, 200 adult individuals with asthma using
asthma medication were invited to take part in phase 2
of the current study i.e. the validating of the developed
adherence questionnaire. They were randomly selected
from the asthma cohort in the clinical phase of the
WSAS. They had not been included in phase 1 described
above. They received the adapted questionnaire and, in
addition, the Medication Adherence Report Scale
(MARS) [25]. One initial mailing of the questionnaire
and one reminder were sent. A completed and returned
questionnaire was regarded as consent to participate in
the study.
Phase 3 - assessment of adherence in relation to
personality traits and achieved goals using the developed
questionnaire
The sample in phase 3 consisted of the same respon-
dents as in phase 2 described above. The respondents
completed the following questionnaires on personality
traits and goals with the asthma medication:
In order to assess personality traits, the Neuroticism,
Extraversion and Openness to Experience Five-Factor
Inventory (NEO-FFI) consisting of 60 items, scaled 1–5,
was used [15].
In order to assess goals with the asthma medication
treatment the following two questions were used:
1. “What is your goal with your asthma medication?”
This was an open question and the respondents
stated their personal goals with the asthma
medication.
2. “Do you think that your goal with your asthma
medication has been reached?” This question was
used to assess whether the stated goal with the
asthma medication was reached or not. Yes and no
were used as response alternatives.
Analyses – phases 1–3
The study samples were described using descriptive sta-
tistics, i.e. frequencies, percentages, means and standard
deviations [26]. Factor analysis, i.e. principal component
analysis with Varimax and Kaiser normalization as the
rotation method, was used to explore associations be-
tween the items, to remove redundant items and to
identify underlying constructs among the items [27].
Cronbach’s alpha was used to test the reliability of the
scales in the developed adherence questionnaire [26]. In
order to demonstrate validity, Pearson’s correlation coef-
ficient was used to determine associations between
responses to the new questionnaire and the MARS (in
phase 2) [23]. Associations between adherence and
personality traits were investigated using Pearson’s
correlation coefficient and a multiple regression model. T-
tests were used to study differences between subgroups.
All statistical analyses were performed using SPSS version
20. Reports on goals with the asthma medication were
compiled into categories according to content.
Ethical considerations
The study was approved by the regional research ethics
board at the University of Gothenburg reference number
926–12 and adhered to Declaration of Helsinki-Ethical
Principles for Medical Research Involving Human
Subjects [28].
Results
Phase 1 – questionnaire development
Out of the 300 individuals with asthma who were invited
to participate, 157 returned completed questionnaires,
resulting in a response-rate of 52 %. Regarding disease
severity, 15 % of the 157 respondents had made an
emergency visit due to asthma during the last 12 months.
Additional characteristics of the respondents are
presented in Table 2. It has been recommended that
items with high/low endorsement should be avoided in
questionnaires, as a skewed distribution leads to poor
discriminatory power. For that reason, items were
considered for removal if ≤ 20 % or ≥ 80 % of the re-
sponses endorsed either “Doesn’t correspond at all”/
“Doesn’t correspond very well” or “Corresponds fairly
well”/”Corresponds exactly”) [22]. Eventually, 29 items
that did not show a good response spread were removed
from further analysis. Table 1 shows the 17 items that
were used in the subsequent psychometric analyses.





Frequencies (%) Frequencies (%)
Men 66 (42) 39 (38)
Women 91 (58) 65 (62)
Age mean (SDa) 50 (15) 49 (14)
Asthma inhalers
Corticosteroids 64 (41) 38 (36)
Combination therapy (corticosteroids
+ long-acting beta2-agonists)
40 (25) 30 (29)
Short-acting beta2-agonists 84 (53) 64 (61)
Long-acting beta2-agonists 17 (10) 10 (9)
astandard deviation
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Two factor analyses were conducted. In the first factor
analysis with 17 items (Table 1), the Kaiser-Meyer-Olkin
and Bertlett’s test showed a sampling adequacy of 0.766,
approx. and a significance of <0.001. The analysis
resulted in five components with an Eigenvalue >1,
which were consistent with the generated scree plot.
The variance was 62.67 %. The internal consistency of
the five preliminary components was measured using
Cronbach’s α. The consistency analysis showed that the
three items with the lowest loadings (≤0.45 in the first
two factors and <0.65 in the third factor) on each of the
three first components also had the lowest corrected
item-total correction and lowered the Cronbach’s α. The
four items underlying the fourth and fifth component
had a Cronbach’s α ≤ 0.7 and were discarded from
further analyses. An α ≥ 0.7 is recommended for a ques-
tionnaire that is under development, while an α ≥ 0.8 is
recommended for a more established one [23]. In total,
seven items were removed before proceeding to the next
analysis.
The second factor analysis was based on the ten
remaining items (Table 1). The Kaiser-Meyer-Olkin and
Bertlett’s test showed a sampling adequacy of 0.745,
approx. and a significance of <0.001. The analysis re-
sulted in three components with an Eigenvalue >1,
which were consistent with the scree plot. The variance
was 69.31 %. The three factors were named “medication
routines”, “self-adjusting the medication” and “concerns
about side-effects”; they were then subjected to
reliability tests. The factor loadings and Cronbach’s α are
presented in Table 3.
Phase 2– validation of the questionnaire developed in
phase 1 described above
Out of the 200 individuals with asthma who were invited
to participate in the validating of the questionnaire, 104
returned completed questionnaires, resulting in a re-
sponse rate of 52 %. Regarding disease severity, 16 % of
the 104 respondents had made an emergency visit due
to asthma during the last 12 months. Additional charac-
teristics of the respondents are presented in Table 2.
In the factor analysis with the ten items selected from
phase 1, the Kaiser-Meyer-Olkin and Bertlett’s test
showed a sampling adequacy of 0.811, approx. and a sig-
nificance <0.001. The analysis resulted in a three-factor
solution with an Eigenvalue > 1, which was consistent
with the scree plot. The variance was 79.91 %. The three
components - “medication routines”, “self-adjusting the
medication” and “medication concerns” - were then sub-
jected to reliability tests. The factor loadings and Cron-
bach’s α are presented in Table 4.
In order to demonstrate validity, responses to the de-
veloped questionnaire were compared with responses to
the MARS to measure convergent and discriminant val-
idity [23]. Responses to all items except the two covering
concerns about the asthma medication correlated with
the responses to the MARS (Table 5). The items in the
three generated components were summarized and then
Table 3 Factor loadings from Principal component analysis with Varimax and Kaiser normalization as the rotation method for the







“medication routines” Cronbach’s α = 0.802
It’s easy to forget asthma medicine. 0.842 -0.018 0.027
I don’t have any real habits for my asthma medicine but instead I take
them when I remember to.
0.794 0.243 -0.089
I’m like a periodical drinker as far as my asthma medicine is concerned. 0.723 0.252 0.011
Sometimes I test going without my asthma medicine to see what it’s like. 0.627 0.303 0.085
I don’t use my asthma medicine exactly like my doctor has said. 0.500 0.458 0.305
“self-adjusting the medication” Cronbach’s α =0.769
I don’t really follow the instructions for my asthma medicine but instead
I can feel what my body needs. If I feel I need more, I take more. If I feel
I need less, I take less.
0.182 0.900 0.047
I can tell myself how I feel and how much of my asthma medicine I
need to take.
0.132 0.779 -0.188
I don’t follow the doctor’s prescription exactly but instead I can feel
what I need to take.
0.275 0.698 0.086
“concerns about side-effects” Cronbach’s α = .922
I’m worried about how my asthma medicine will affect my body in
the long run.
0.009 -0.034 0.949
I worry about the side-effects of asthma medicine. 0.036 0.016 0.957
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measured against the MARS. The components called
“medication routines” and “self-adjusting the medica-
tion” both correlated with the MARS. The component
called “medication concerns” was not associated with
the MARS (Table 5).
Phase 3 - assessment of adherence in relation to
personality traits and achieved goals
Descriptive statistics of personality traits and the devel-
oped adherence questionnaire are presented in Table 6.
Neuroticism was positively associated with the scale
called “medication routines” in the developed question-
naire (r = 0.321, p = 0.002), indicating that respondents
scoring higher on this personality trait reported poorer
adherence. Conscientiousness was negatively associated
with the scale called “medication routines” (r =−0.313, p =
0.002) indicating that respondents scoring higher on this
personality trait were more likely to be adherent to the pre-
scribed asthma medication. No other associations were
identified between the investigated personality traits and
the developed adherence questionnaire.
In a multiple regression model (F 8.19, p = 0.001) explain-
ing 13.6 % of the variance in the in adherence scale called
“medication routines”, Neuroticism was identified as a
positive predictor (B = 0.185, β = 0.242, p = 0.021) and
Conscientiousness as a negative predictor (B = −2.44,
β = −0.242, p = 0.021).
Regarding goals with the medication, 27 % of the
respondents stated that they had not achieved their goal
with the asthma medication. These respondents scored
higher on the scale “medication routine” compared to
respondents having achieved their goal (mean 13.63 SD
6.67 versus mean 10.00 SD 5.70), indicating poorer
adherence. Six categories of goals with the asthma
medication were reported: “To reduce the medication”,
“To feel well”, “Symptom relief”, “Have a normal life”,
“Enabling and facilitating physical activity” and “Long-
term goals regarding the disease progress”.
Discussion
The current study sought to develop a questionnaire with
discriminatory power to measure adherence to asthma
medication in adult individuals with asthma. An item pool
was constructed that was based on our previous research
and knowledge focusing adherence. Based on individuals
with asthma randomly selected from the general popula-
tion, who completed the initial questionnaire, ten items
were selected and a revised version of the questionnaire
was evaluated among another group of individuals with
asthma also randomly selected from the general popula-
tion. The final questionnaire contains three subscales-
“medication routines”, “self-adjusting the medication” and
“concerns about side-effects -, of which two correlated
well with an established adherence questionnaire. The
personality traits Neuroticism and Conscientiousness were
associated with the subscale “medication routines”.
Respondents who had not achieved their goals with the
asthma medication reported poorer adherence.
Table 4 Factor loadings from Principal component analysis with Varimax and Kaiser normalization as the rotation method for the







“medication routines” Cronbach’s α = 0.880
It’s easy to forget asthma medicine. 0.886 0.192 0.017
I’m like a periodical drinker as far as my asthma medicine is concerned. 0.829 0.340 -0.096
I don’t have any real habits for my asthma medicine but instead I take
them when I remember to.
0.820 0.350 -0.014
Sometimes I test going without my asthma medicine to see what it’s like. 0.678 0.150 0.293
I don’t use my asthma medicine exactly like my doctor has said. 0.606 0.441 0.148
“self-adjusting the medication” Cronbach’s α = .919
I don’t really follow the instructions for my asthma medicine but instead
I can feel what my body needs. If I feel I need more, I take more. If I feel I
need less, I take less.
0.260 0.889 0.038
I can tell myself how I feel and how much of my asthma medicine I
need to take.
0.287 0.877 0.011
I don’t follow the doctor’s prescription of asthma medicine exactly but
instead I can feel how much I need to take.
0.333 0.861 0.048
“concerns about side-effects” Cronbach’s α = 0.927
I’m worried about how my asthma medicine will affect my body in
the long run.
0.039 0.049 0.959
I worry about the side-effects of asthma medicine. 0.081 0.018 0.956
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The removal of several items that were regarded as
having high/low endorsement was made to increase the
possibility of discriminating the reported adherence. For
instance, the MARS [25] has shown a skewed distribu-
tion in previous research [12, 14, 29], which could result
in an overestimation of adherence. Consequently, the
removal of the items with high/low endorsement was
considered as a measure to enable a good response
spread to facilitate the identification of high or low
adherers, which could be viewed as an advantage with
the developed questionnaire. The removal of the items
could also be regarded as a limitation because it may
affect both the respondents’ reporting on their beliefs
and the distribution of their positions.
One strength is that the items in the final question-
naire were selected through analyses based on data
derived from individuals with asthma selected at random
from the general population. The focus of any question-
naire must be relevant to its target group [23], and
participants in the current study consisted of individuals
with asthma who had reported use of asthma medica-
tion, which could be a strength considering representa-
tiveness. However, as adherence to medication treatment
tends to fluctuate over time, it may be a possible limita-
tion that the current study did not provide data on the
duration of the medication treatment. Moreover, the
response-rate could have been higher, which could be
seen as a shortcoming considering representativeness as
it may be that those who chose to participate were those
who were attentive to the medication treatment. Never-
theless, the sample sizes in both phase 1–3 (each with at
least 100 participants) were considered sufficiently large
enough. In addition, both samples were selected at
random from a population-based study, which in turn
consisted of participants selected at random, which
could be regarded as a strength [27].
An additional strength of the current study may be
that the questionnaire developed in phase 1 was tested
in phase 2 and that the validity of the final questionnaire
was tested in relation to a previously validated instru-
ment, i.e. the MARS [25]. Responses to all items in the
subscales “medication routines and “self-adjusting the
medication” correlated with the responses to the MARS,
which could be considered an appropriate validity check.
It could be seen as a shortcoming that the developed
questionnaire was not tested in relation to a more
objective measure of adherence, for instance electronic
monitoring of medication use. The scale “medication
concerns” was not associated with the MARS, and thus
removal of this subscale may be called for. However,
concerns with asthma medication are to be regarded as
one influencing factor of adherence [29].
Regarding personality and adherence, the current
showed that the scale “medication routines” in the devel-
oped questionnaire – was associated with the personality
traits Neuroticism and Conscientiousness. These
findings are consistent with previous research focusing
on personality traits and adherence to asthma medica-
tion [12–14] but also with adherence in relation to other
long-term medication treatments [30–33]. Individuals
Table 6 Means and standard deviations (SD) of personality
traits and the developed adherence questionnaire (n = 104)
Personality traits Mean (SD)
Neuroticism 27.57 (7.51)
Extraversion 43.45 (6.85)




Medication routines 11.11 (6.12)
Self-adjusting the medication 8.64 (4.34)
Medication concerns 4.07 (2.53)
Table 5 Pearson’s correlation coefficients between the
developed questionnaire and the MARSa - phase 2
Variables MARSa
Items
1 It’s easy to forget asthma medicine. -0.659b
1 I don’t have any real habits for my asthma medicine
but instead I take them when I remember to.
-0.682b
1 I’m like a periodical drinker as far as my asthma
medicine is concerned.
-0.649b
1 Sometimes I test going without my asthma
medicine to see what it’s like.
-0.561b
1 I don’t use my asthma medicine exactly like my
doctor has said.
-0.591b
2 I don’t really follow the instructions for my asthma
medicine but instead I can feel what my body needs.
If I feel I need more, I take more. If I feel I need less,
I take less.
-0.596b
2 I can tell myself how I feel and how much of my asthma
medicine I need to take.
-0.621b
2 I don’t follow the doctor’s prescription of asthma medicine
exactly but instead I can feel how much I need to take.
-0.654b
3 I’m worried about how my asthma medicine will affect
my body in the long run.
-0.094
3 I worry about the side-effects of asthma medicine. -0.151
Scales
medication routines -0.762b
self-adjusting the medication -0.676b
medication concerns -0.126
aThe Medication Adherence Report Scale
bCorrelation is significant at the 0.01 level (2-tailed)
1 = item in the scale: medication routines
2 = item in the scale: self-adjusting the medication
3 = item in the scale: medication concerns
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who score higher on Neuroticism have reported poorer
adherence to asthma medication treatment [14] and in
relation to other long-term therapies [20, 33]. The
personality trait Neuroticism measures degrees of emo-
tional stability. Persons scoring higher on this trait could
be more inclined to be worried, anxious, depressive and
vulnerable to stress [15], which are characteristics that
may explain the poorer adherence among individuals
scoring higher on Neuroticism. Anxiety and depression,
which are prevalent among individuals with asthma [34],
have previously been associated with poorer adherence
to asthma medication treatment [35]. For future studies,
it would be advisable to include measures of anxiety and
depression when assessing adherence to asthma medica-
tion treatment.
In contrast to Neuroticism, individuals scoring higher
on Conscientiousness have reported higher adherence
both in relation to asthma medication treatment [13, 14]
and other medication treatments [30–33]. Importantly,
the current study shows that individuals who had
reached their goals with the asthma medication also
reported better adherence, which indicates that adherence
is of significance if personal goals with the asthma medica-
tion are to be achieved. Therefore, the current study
suggests that individual goals with the asthma medication
are discussed with the patients during follow-up consulta-
tions and that the set goals are used as inducement to
promote adherence.
Conclusions
A questionnaire consisting of three subscales - “medica-
tion routines”, “self-adjusting the medication” and
“concerns about side-effects - of which two measure
adherence behavior in relation to asthma medication and
one measures concerns about the asthma medication–
was developed and tested among individuals with asthma.
The questionnaire appears to be useful for estimations of
adherence to asthma medication in adult individuals with
asthma but further testing is recommended. Two of the
investigated personality traits – Neuroticism and Con-
scientiousness – were associated with one of the scales in
the developed adherence questionnaire. Respondents who
reported not having achieved their goal with the asthma
medication reported poorer adherence.
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